MetLife (NYSE:MET – Get Free Report) declared that its board has initiated a share repurchase plan on Wednesday, August 5th, RTT News reports. The company plans to repurchase $3.00 billion in shares. This repurchase authorization allows the financial services provider to purchase up to 4.8% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company’s management believes its shares are undervalued.
MetLife Stock Performance
MET stock traded up $0.32 during trading hours on Wednesday, reaching $96.45. The stock had a trading volume of 4,686,212 shares, compared to its average volume of 3,968,851. The stock has a 50-day simple moving average of $89.44 and a 200 day simple moving average of $80.54. MetLife has a fifty-two week low of $67.33 and a fifty-two week high of $97.80. The stock has a market capitalization of $62.06 billion, a PE ratio of 18.69, a price-to-earnings-growth ratio of 0.74 and a beta of 0.78. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.20 and a quick ratio of 0.20.
MetLife (NYSE:MET – Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $2.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.30 by $0.13. MetLife had a return on equity of 22.60% and a net margin of 4.66%.The company had revenue of $19.07 billion during the quarter, compared to analysts’ expectations of $19.67 billion. During the same period last year, the firm posted $2.02 earnings per share. The business’s revenue was up 10.5% on a year-over-year basis. Analysts predict that MetLife will post 9.89 EPS for the current fiscal year.
MetLife Dividend Announcement
Wall Street Analysts Forecast Growth
Several equities research analysts have commented on the company. Keefe, Bruyette & Woods boosted their target price on MetLife from $98.00 to $105.00 and gave the company an “outperform” rating in a research note on Monday, July 13th. UBS Group lifted their price objective on shares of MetLife from $102.00 to $105.00 and gave the company a “buy” rating in a report on Wednesday, July 8th. TD Cowen boosted their price objective on shares of MetLife from $87.00 to $105.00 and gave the stock a “buy” rating in a research report on Wednesday, July 22nd. Evercore set a $96.00 target price on shares of MetLife in a report on Thursday, April 9th. Finally, Jefferies Financial Group lifted their price target on shares of MetLife from $97.00 to $103.00 and gave the company a “buy” rating in a research note on Friday, July 10th. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, MetLife has a consensus rating of “Moderate Buy” and an average target price of $100.50.
Read Our Latest Analysis on MetLife
MetLife Company Profile
MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.
In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.
Featured Stories
- Five stocks we like better than MetLife
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
